左卡尼汀在老年糖尿病肾病维持性血液透析患者中的应用价值
CSTR:
作者:
作者单位:

(空军军医大学唐都医院肾脏内科,西安 710038)

作者简介:

通讯作者:

中图分类号:

基金项目:

陕西省重点研发计划(S2022-YF-YBSF-0330)


Application value of levocarnitine in elderly patients with diabetic kidney disease on maintenance hemodialysis
Author:
Affiliation:

(Department of Nephrology, Tangdu Hospital of Air Force Medical University, Xi′an 710038, China)

Fund Project:

This work was supported by the Key Research and Development Program of Shaanxi Province (S2022-YF-YBSF-0330).

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨左卡尼汀在老年糖尿病肾病(DKD)维持性血液透析(MHD)患者中的应用价值。方法 选择2023年1月至12月空军军医大学第二附属医院收治的252例行MHD治疗的老年DKD患者为研究对象,将患者随机分为左卡尼汀组(常规干预+左卡尼汀,126例)与对照组(常规干预,126例),两组老年患者入组后均连续治疗3个月。比较两组治疗前及治疗3个月后实验室指标变化,记录治疗期间不良反应发生情况。采用SPSS 24.0统计软件进行数据分析。根据数据类型分别采用t检验或χ2检验行进行组间比较。结果 252例患者中,两组各有3例予以剔除。治疗3个月后,两组患者血清β2微球蛋白(β2-MG)、血肌酐(SCr)、血尿素氮(BUN)、甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、脂蛋白相关磷脂酶A2(Lp-PLA2)、C反应蛋白(CRP)及白细胞介素6(IL-6)水平均较治疗前显著降低,且左卡尼汀组低于对照组,差异有统计学意义(P<0.05)。两组患者血清白蛋白(ALB)、老年营养风险指数(GNRI)及高密度脂蛋白胆固醇(HDL-C)均显著升高,且左卡尼汀组高于对照组,差异有统计学意义(P<0.05)。治疗3个月后,两组患者空腹血糖(FBG)、餐后2h血糖(2hPG)、糖化血红蛋白(HbA1c)均较治疗前显著降低,差异有统计学意义(P<0.05);但两组治疗后比较,差异无统计学意义(P>0.05)。左卡尼汀组与对照组不良反应发生率分别为3.25%、0.00%,两组比较差异无统计学意义(P>0.05)。结论 左卡尼汀联合常规对症治疗对于行MHD治疗的老年DKD患者应用价值较高,能改善脂代谢及营养状态,减轻炎症反应,可能对保护患者肾功能有利。

    Abstract:

    Objective To explore the application value of levocarnitine in elderly patients with diabetic kidney disease (DKD) on maintenance hemodialysis (MHD). Methods A total of 252 elderly DKD patients receiving MHD treatment in our hospital from January 2023 to December 2023 were recruited and then randomly divided into a levocarnitine group (routine treatment + levocarnitine, 126 cases) and a control group (routine treatment, 126 cases). After three months of continuous treatment, the changes in laboratory indicators were compared before and after treatment and between the two groups. The incidence of adverse reactions during treatment were observed and recorded. SPSS statistics 24.0 was used for data analysis, and t test or Chi-square test was used for between-group comparison depending on data type. Results Among 252 patients, three cases in each group were excluded. After three months of treatment, the levels of serum β2-microglobulin (β2-MG), serum creatinine (SCr), blood urea nitrogen (BUN), triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), lipoprotein-associated phospholipase A2 (Lp-PLA2), C-reactive protein (CRP) and interleukin-6(IL-6) were significantly reduced in both groups when compared with those before treatment, and these above levels were obviously lower in the levocarnitine group than the control group (P<0.05). Serum albumin (ALB), geriatric nutritional risk index (GNRI) and high-density lipoprotein cholesterol (HDL-C) were significantly risen in the two groups than those before treatment, and these indicators were notably higher in the levocarnitine group than the control group (P<0.05). The levels of fasting blood glucose (FBG), 2h postprandial blood glucose (2hPG) and glycosylated hemoglobin (HbA1c) were significantly declined in both groups after three months of treatment than the levels before treatment (P<0.05), but there were no statistical differences between groups after treatment (P>0.05). No notable difference was observed in the incidence of adverse reactions between the levocarnitine group and the control group (3.25% vs 0.00%, P>0.05). Conclusion Levocarnitine combined with routine symptomatic treatment has high application value in the elderly DKD patients on MHD. It can improve lipid metabolism and nutritional status, and relieve inflammatory response, and may be beneficial to protecting renal function in the patients.

    参考文献
    相似文献
    引证文献
引用本文

王欢,张姣姣,王锋利,吕红红.左卡尼汀在老年糖尿病肾病维持性血液透析患者中的应用价值[J].中华老年多器官疾病杂志,2025,24(8):573-577
DOI:10.11915/j. issn.1671-5403.2025.08.125

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2024-08-12
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-08-25
  • 出版日期:
文章二维码